NGNE
Neurogene Inc
30.90$
-7.9%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | -100.0% | |
| – | – | – | – | – | – | +435.6% | +2,220.9% | -92.4% | +2.1% | -0.5% | -1.7% | |
| – | – | – | – | – | -101.4% | – | – | – | – | – | – | |
| – | -12.0% | +79.6% | +27.8% | -9.6% | -80.7% | +285.4% | +73.6% | +12.4% | -6.5% | +37.2% | +23.1% | |
| – | – | – | – | – | – | – | – | +9.0% | +24.2% | +102.1% | +25.2% | |
| – | -4.0% | +76.4% | +35.8% | -5.1% | -50.3% | +64.8% | -79.2% | +544.8% | -1.9% | +53.4% | +24.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -95.6% | -99.0% | +300.0% | +0.0% | -75.0% | – | – | – | +500.0% | +0.0% | -58.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | -100.0% | – | -129.4% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.